SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.16-3.2%Dec 1 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (16463)11/22/2003 9:45:06 AM
From: Robert K.  Read Replies (1) of 17367
 
Blue> posted this at the swamp FYI
>Besides the xoma/DNA?SRA PR and newsflow you will also be seeing lots of Free PR
This story is a find from blue of SI.
Take special note of the (two horse race)
and the last comment in the article.
Like I have been saying the MARKET itself will continue to expand. Being in a 2 horse race and getting mentioned with >JUST< Enbrel is a good thing IMO. Huge market, many indications.
A 2 horse race in immunological biologicals is logicals IMO. skd >Read below.
>http://www.lifeclinic.com/healthnews/article_view.asp?story=516122
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext